Stocks / NASDAQ / Scilex Holding Company

Scilex Holding Company

Our Opinion

Scilex Holding Company is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

“Histopathology clean with SP-102 in both routine and special stains, NOAEL is highest dose tested 10
mg/animal single dose & repeat dose” (Page 29) Read the full document

Company Description

Scilex Holding Company, a biopharmaceutical company, focuses on acquiring, developing, and commercializing non-opioid management products for the treatment of acute and chronic pain. It offers ZTlido, a prescription lidocaine topical product for the relief of neuropathic pain related with postherpetic neuralgia, which is a form of post-shingles nerve pain. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.

Company Website: